Australian Pharmaceuticals & Biotech Healthy potentially undervalued

Clinuvel Pharmaceuticals

Market Cap: AU$525.5m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Radiopharm Theranostics

Market Cap: AU$43.4m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

CSL

Market Cap: AU$80.6b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.